(secondQuint)Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population.

 The purpose of this study is to evaluate the overall COPD patient experience with the Nuvaira cent Lung Denervation System and allow for the continued collection of safety and effectiveness data on the CE-marked product.

 The study is a multicenter, prospective, single-arm study designed to include patients, on average, who fall within a more severe stage of COPD, defined as 20-45% FEV1 percent predicted.

 Subjects will remain on respiratory medications per their standard of care and will be followed and tested per standard of care throughout the study.

.

 Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population@highlight

The DISCOVER TLD study is a multicenter, prospective, single-arm study designed to record the clinical outcomes of the CE-marked Nuvaira cent Lung Denervation System, in a subset of its CE-marked approved indication.

 This study is being conducted in Europe.

